Cytomegalovirus pneumonia in patients with inflammatory bowel disease: A systematic review

International Journal of Infectious Diseases

Volumn 16, Issue 7, 2012, Pages

  Cascio, Antonio ^a,b   Iaria, Chiara ^b   Ruggeri, Paolo ^c   Fries, Walter ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Azienda Ospedaliera Piemonte Papardo   (Italy)

Author keywords

Crohn's diseases; Cytomegalovirus; Hemophagocytic lymphohistiocytosis; Inflammatory bowel diseases; Pneumonia; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN A; ETOPOSIDE; FOSCARNET; GANCICLOVIR; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; PREDNISONE; VALGANCICLOVIR;

AGE DISTRIBUTION; CYTOMEGALOVIRUS INFECTION; CYTOMEGALOVIRUS PNEUMONIA; DEATH; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPNEA; ENTERITIS; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; INTENSIVE CARE UNIT; LUNG INFILTRATE; PNEUMONIA; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; PNEUMONIA, VIRAL; RISK FACTORS; VIRUS ACTIVATION;

EID: 84862535610     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.03.008     Document Type: Review

References (46)

1. Kim J.J., Simpson N., Klipfel N., Debose R., Barr N., Laine L. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci 2010, 55:1059-1065.
2. Kuwabara A., Okamoto H., Suda T., Ajioka Y., Hatakeyama K. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol 2007, 42:823-829.
3. Matsuoka K., Iwao Y., Mori T., Sakuraba A., Yajima T., Hisamatsu T., et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol 2007, 102:331-337.
4. Nguyen M., Bradford K., Zhang X., Shih D.Q. Cytomegalovirus reactivation in ulcerative colitis patients. Ulcers 2011, 2011. pii: 282507.
5. Sato S., Kobayashi H., Saito R., Sasajima T., Orikasa H., Watanabe H., et al. A case of steroid-refractory ulcerative colitis complicated with cytomegalovirus pneumonia. Fukushima J Med Sci 2007, 53:27-32.
6. Basseri B., Enayati P., Marchevsky A., Papadakis K.A. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J Crohns Colitis 2010, 4:390-397.
7. Casella G., Villanacci V., Di Bella C., Antonelli E., Baldini V., Bassotti G. Pulmonary diseases associated with inflammatory bowel diseases. J Crohns Colitis 2010, 4:384-389.
8. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009, 6:e1000100.
9. Sijpkens Y.W., Allaart C.F., Thompson J., van't Wout J., Kluin P.M., den Ottolander G.J., et al. Fever and progressive pancytopenia in a 20-year-old woman with Crohn's disease. Ann Hematol 1996, 72:286-290.
10. Papadakis K.A., Tung J.K., Binder S.W., Kam L.Y., Abreu M.T., Targan S.R., et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol 2001, 96:2137-2142.
11. Hookey L.C., Depew W., Boag A., Vanner S. 6-mercaptopurine and inflammatory bowel disease: hidden ground for the cytomegalovirus. Can J Gastroenterol 2003, 17:319-322.
12. Alderson J.W., Van Dinter T.G., Opatowsky M.J., Burton E.C. Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature. MedGenMed 2005, 7:7.
13. Piton G., Dupont-Gossart A.C., Weber A., Herbein G., Viennet G., Mantion G., et al. Severe systemic cytomegalovirus infections in patients with steroid-refractory ulcerative colitis treated by an oral microemulsion form of cyclosporine: report of two cases. Gastroenterol Clin Biol 2008, 32:460-464.
14. de Boer N.K., van Bodegraven A.A., de Graaf P., van der Hulst R.W., Zoetekouw L., van Kuilenburg A.B. Paradoxical elevated thiopurine S-methyltransferase activity after pancytopenia during azathioprine therapy: potential influence of red blood cell age. Ther Drug Monit 2008, 30:390-393.
15. Wolschke C., Fiedler W., Habermann R.C., Janka-Schaub G.E., Kluge S. [28-year old female patient with respiratory insufficiency, elevated liver enzymes, pancytopenia and fever]. Internist (Berl) 2010, 51:1434-1438.
16. N'Guyen Y., Baumard S., Salmon J.H., Lemoine L., Leveque N., Servettaz A., et al. Cytomegalovirus associated hemophagocytic lymphohistiocytosis in patients suffering from Crohn's disease treated by azathioprine: a series of four cases. Inflamm Bowel Dis 2011, 17:E116-E118.
17. Lo Presti M.A., Costantino G., Della Torre A., Belvedere A., Cascio A., Fries W. Severe CMV-related pneumonia complicated by the hemophagocytic lymphohistiocytic (HLH) syndrome in quiescent Crohn's colitis: harmful cure?. Inflamm Bowel Dis 2011, 17:145-146.
18. van Langenberg D.R., Morrison G., Foley A., Buttigieg R.J., Gibson P.R. Cytomegalovirus disease, haemophagocytic syndrome, immunosuppression in patients with IBD: 'a cocktail best avoided, not stirred'. J Crohns Colitis 2011, 5:469-472.
19. Cottone M., Pietrosi G., Martorana G., Casa A., Pecoraro G., Oliva L., et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol 2001, 96:773-775.
20. Petrache A., Moller M.B., Frederiksen H. [Hemophagocytosis associated with cytomegalovirus infection and azathioprine treatment for inflammatory bowel disease]. Ugeskr Laeger 2010, 172:52-53.
21. Kak V., Havlichek D. Fulminant cytomegaloviral pneumonia after infliximab in a patient with Crohn disease. Infect Dis Clin Pract 2004, 12:311-313.
22. Brant S.R., Nguyen G.C. Is there a gender difference in the prevalence of Crohn's disease or ulcerative colitis?. Inflamm Bowel Dis 2008, 14(Suppl 2):S2-S3.
23. Mowat C., Cole A., Windsor A., Ahmad T., Arnott I., Driscoll R., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011, 60:571-607.
24. Lichtenstein G.R., Hanauer S.B., Sandborn W.J. Management of Crohn's disease in adults. Am J Gastroenterol 2009, 104:465-483. quiz 4, 84.
25. Dignass A., Van Assche G., Lindsay J.O., Lemann M., Soderholm J., Colombel J.F., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: current management. J Crohns Colitis 2011, 4:28-62.
26. Travis S.P., Stange E.F., Lemann M., Oresland T., Bemelman W.A., Chowers Y., et al. European evidence-based consensus on the management of ulcerative colitis: current management. J Crohns Colitis 2008, 2:24-62.
27. Seksik P., Cosnes J., Sokol H., Nion-Larmurier I., Gendre J.P., Beaugerie L. Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine. Aliment Pharmacol Ther 2009, 29:1106-1113.
28. Beaugerie L., Brousse N., Bouvier A.M., Colombel J.F., Lemann M., Cosnes J., et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009, 374:1617-1625.
29. Meyers J.D., Flournoy N., Thomas E.D. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986, 153:478-488.
30. Uberti-Foppa C., Lillo F., Terreni M.R., Puglisi A., Guffanti M., Gianotti N., et al. Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease. Chest 1998, 113:919-923.
31. Itaba S., Iwasa T., Sadamoto Y., Nasu T., Misawa T., Inoue K., et al. Pneumocystis pneumonia during combined therapy of infliximab, corticosteroid, and azathioprine in a patient with Crohn's disease. Dig Dis Sci 2007, 52:1438-1441.
32. Stas P., D'Hoore A., Van Assche G., Geboes K., Steenkiste E., Penninckx F., et al. Miliary tuberculosis following infliximab therapy for Crohn disease: a case report and review of the literature. Acta Gastroenterol Belg 2006, 69:217-220.
33. Lawrance I.C., Radford-Smith G.L., Bampton P.A., Andrews J.M., Tan P.K., Croft A., et al. Serious infections in patients with inflammatory bowel disease receiving anti-tumor necrosis factor-alpha therapy: an Australian and New Zealand experience. J Gastroenterol Hepatol 2010, 25:1732-1738.
34. Monaghan T.M., Norton B. Varicella pneumonia in an immunocompromised inflammatory bowel disease patient. Inflamm Bowel Dis 2010, 16:364-365.
35. Lemyze M., Tavernier J.Y., Chevalon B., Lamblin C. [Severe varicella zoster pneumonia during the course of treatment with azathioprine for Crohn's disease]. Rev Mal Respir 2003, 20:773-776.
36. Stratakos G., Kalomenidis I., Papas V., Malagari K., Kollintza A., Roussos C., et al. Cough and fever in a female with Crohn's disease receiving infliximab. Eur Respir J 2005, 26:354-357.
37. Dotson J.L., Crandall W., Mousa H., Honegger J.R., Denson L., Samson C., et al. Presentation and outcome of histoplasmosis in pediatric inflammatory bowel disease patients treated with antitumor necrosis factor alpha therapy: a case series. Inflamm Bowel Dis 2011, 17:56-61.
38. Rahier J.F., Papay P., Salleron J., Sebastian S., Ellul P., Teich N., et al. Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series. Aliment Pharmacol Ther 2011, 33:499-500.
39. Ahmad N.M., Ahmad K.M., Younus F. Severe adenovirus pneumonia (AVP) following infliximab infusion for the treatment of Crohn's disease. J Infect 2007, 54:e29-e32.
40. Nausheen S., Cunha B.A. Q fever community-acquired pneumonia in a patient with Crohn's disease on immunosuppressive therapy. Heart Lung 2007, 36:300-303.
41. Epping G., van der Valk P.D., Hendrix R. Legionella pneumophila pneumonia in a pregnant woman treated with anti-TNF-alpha antibodies for Crohn's disease: a case report. J Crohns Colitis 2010, 4:687-689.
42. Ananthakrishnan A.N., Attila T., Otterson M.F., Lipchik R.J., Massey B.T., Komorowski R.A., et al. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. J Clin Gastroenterol 2007, 41:682-688.
43. Nagy F., Molnar T., Makula E., Kiss I., Milassin P., Zollei E., et al. A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine. World J Gastroenterol 2007, 13:316-319.
44. van Duin D., Miranda C., Husni E. Cytomegalovirus viremia, pneumonitis, and tocilizumab therapy. Emerg Infect Dis 2011, 17:754-756.
45. Gupta S., Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol 2010, 6:137-154.
46. Raschke R.A., Garcia-Orr R. Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults. Chest 2011, 140:933-938.